Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Olainfarm Drugmaker Jumps to Record on Tax Exemption: Riga Mover

Don't Miss Out —
Follow us on:

May 10 (Bloomberg) -- AS Olainfarm, a Latvian drugmaker with sales in 30 countries, extended record gains as Swedbank AB raised its share-price estimate for the stock after the company got a tax break from the government.

The stock rose as much as 4.5 percent in Riga and closed up 2.7 percent at 5.01 lats, the highest since trading began in 1998. Volume of 9,782 shares was the equivalent of 183 percent of the three-month daily average, according to data complied by Bloomberg. The shares have jumped 36 percent this year, extending last year’s 50 percent increase and valuing the company at 70.6 million lats ($131 million).

Swedbank raised its price estimate to 5.1 lats from 4.8 lats after Olainfarm said on May 8 that the Latvian government had given it a tax exemption of as much as 5.2 million lats for investments in new products and capacity.

The bank cut its recommendation to neutral from buy, citing “the recent rally in the share price,” Marek Randma, head of Baltic equity research, said in a note yesterday, when the Latvian stock market was closed for a European holiday.

To contact the reporter on this story: Bryan Bradley in Vilnius at

To contact the editor responsible for this story: Balazs Penz at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.